Clinical trials
Phase 3 Vaso-Occlusive Crises trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
| Completed | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Mast Therapeutics, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Abigail Nixon | 1 |
| Asklepion Pharmaceuticals, LLC | 1 |
| AstraZeneca | 1 |
| Baylor College of Medicine | 1 |
| Biossil Inc. | 1 |
| Boston Children's Hospital | 1 |
| Emmaus Medical, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 17 |
| Vaso-Occlusive Crises | 17 |
| Hematologic Diseases | 6 |
| Sickle Cell Trait | 5 |
| Agnosia | 1 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Genetic Diseases, Inborn | 1 |
| Hemoglobinopathies | 1 |
| Hemolysis | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.